Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The presentation and identification of cardiovascular disease in women pose unique diagnostic challenges compared to men, and underrecognized conditions in this patient population may lead to clinical mismanagement.This article reviews the sex differences in cardiovascular disease, explores the diagnostic and prognostic role of cardiovascular magnetic resonance (CMR) in the spectrum of cardiovascular disorders in women, and proposes the added value of CMR compared to other imaging modalities. In addition, this article specifically reviews the role of CMR in cardiovascular diseases occurring more frequently or exclusively in female patients, including Takotsubo cardiomyopathy, connective tissue disorders, primary pulmonary arterial hypertension and peripartum cardiomyopathy. Gaps in knowledge and opportunities for further investigation of sex-specific cardiovascular differences by CMR are also highlighted.

Original publication

DOI

10.1186/s12968-020-00666-4

Type

Journal article

Journal

J Cardiovasc Magn Reson

Publication Date

28/09/2020

Volume

22

Keywords

Cardiovascular magnetic resonance, Chemotherapy-induced cardiomyopathy, Congenital heart disease, Connective tissue disease, Female cardiovascular disease, Ischemic heart disease, Non-ischemic cardiomyopathies, Peripartum cardiomyopathy, Pulmonary hypertension, Turner syndrome, Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Health Status Disparities, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Sex Factors, Women's Health, Young Adult